Anthony N Coles

Affiliations

  • Director at Regeneron Pharmaceuticals Inc. (REGN), 2025-01-06
  • at Cerevel Therapeutics Holdings Inc. (CERE), 2024-08-05
  • Executive Chair at Yumanity Therapeutics Inc. (YMTX), 2021-04-02
  • Director at Mckesson Corp (MCK), 2020-08-19
  • Director at Crispr Therapeutics Ag (CRSP), 2017-06-02
  • Chairman & Ceo at Onyx Pharmaceuticals Inc (ONXX), 2013-10-04
  • Director at Campus Crest Communities Inc. (CCG), 2013-05-31
  • Director at Laboratory Corp Of America Holdings (LH), 2013-02-19
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CERE $41.18 25,000 $1,029,535.00 25,928 2024-07-01 Filing
CERE $40.61 50,000 $2,030,520.00 15,638 2024-06-03 Filing
CERE $42.10 50,000 $2,105,125.00 15,638 2024-05-10 Filing
CERE $42.33 50,000 $2,116,640.00 15,638 2024-04-01 Filing
CERE $41.01 50,000 $2,050,550.00 15,638 2024-03-04 Filing